Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Ginkgo biloba extract (EGb761) for idiopathic sudden sensorineural hearing loss
KCT0001381Phase 4Completed
- Sponsor
- Yuyu Pharma
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ginkgo biloba extract in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Yuyu Pharma. Started Aug 2011; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on KCT0001381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001381.